Emerging diseases likely to be more harmful in similar species

March 17, 2015

When viruses such as influenza and Ebola jump from one species to another, their ability to cause harm can change dramatically, but research from the University of Cambridge shows that it may be possible to predict the virus's virulence by looking at how deadly it is in closely-related species.

A number of emerging infectious diseases - including some of the most deadly outbreaks such as Ebola, SARS and HIV - are the result of humans becoming infected with a pathogen that normally infects another species. The amount of harm caused by a pathogen when it jumps into a new species can be very variable, at times causing few, if any symptoms, while at other times causing high levels of mortality.

A team led by researchers at the Department of Genetics, University of Cambridge, has looked at how the harm a pathogen causes can change following a jump between species. The researchers infected 48 species of fruit fly with an RNA virus, and found that the amount of harm caused by the virus was extremely variable in the new hosts, with some species having relatively benign infections and other species dying rapidly. Most of the deadly emerging diseases that infect humans are caused by RNA viruses.

The different species of fruit fly shared a common ancestor around 40 million years ago. The relationships between the different species can be examined using an evolutionary 'tree' known as a phylogeny. Species that cluster together are the most genetically similar.

In a study published today in the journal PLOS Pathogens, the researchers show that closely related species show similar levels of virulence when infected with the virus, with the tree of species being a patchwork of closely related groups showing high or low virulence. The level of virulence observed appears to be due to the amount of virus that accumulates in the hosts. The viral load also likely affects the ability of the virus to spread.

Although the research was carried out in fruit flies, the researchers suggest that the general principle should be applicable across species. A study published in the journal Science in 2014 showed a pattern consistent with such effects in amphibians infected by chytrid fungus.

"We see such patterns in the wild," explains Dr Ben Longdon. "The Ebola virus, for example, appears to cause few symptoms in its natural reservoir, the fruit bat, but it is deadly in chimpanzees, gorillas and humans.

"While there may be no clear rule to predict how deadly a pathogen will be in a new host, a simple rule of thumb may be that if it causes high levels of virulence in any given host species, it will typically cause similar levels of virulence in closely-related hosts. If we see a new disease emerge that causes high levels of mortality in chimpanzees, for example, then it may also be a danger to humans."
The research was mainly funded by the European Research Council and the Natural Environment Research Council (NERC).

University of Cambridge

Related Ebola Articles from Brightsurf:

Targeting the shell of the Ebola virus
As the world grapples with COVID-19, the Ebola virus is again raging.

Why doesn't Ebola cause disease in bats, as it does in people?
A new study by researchers from The University of Texas Medical Branch at Galveston uncovered new information on why the Ebola virus can live within bats without causing them harm, while the same virus wreaks deadly havoc to people.

Ebola transmission risks would be taken more seriously with ground-up interventions
A study led by the University of Kent's Durrell Institute of Conservation and Ecology (DICE) has found significant differences in disease risk perception and channels of information about Ebola virus disease (EVD) in rural areas and urban centres of Guinea, West Africa.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Ebola antibodies at work
Scientists in Israel and Germany show, on the molecular level, how an experimental vaccine offers long-term protection against the disease.

Half of Ebola outbreaks undetected
An estimated half of Ebola virus disease outbreaks have gone undetected since it was discovered in 1976, according to research published in PLOS Neglected Tropical Diseases.

Protecting those on the frontline from Ebola
Online training developed at the Medical University of South Carolina (MUSC) increased the knowledge of health care workers about effective prevention of Ebola up to 19 percent and reduced critical errors to 2.3 percent in a small MUSC cohort.

Another piece of Ebola virus puzzle identified
A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.

How the human immune system protects against Ebola
'The current approach for treatment of filovirus infections with antibody cocktails tested in animal models utilizes the principle of targeting of non-overlapping epitopes.

How to slow down Ebola
The phylogenetic tree of the 2013-2016 Ebola epidemic doesn't just tell us how the Ebola virus was able to evolve: it also reveals which events and preventive measures accelerated or slowed down its spread.

Read More: Ebola News and Ebola Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.